Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
04/18/2007 | CN1950345A Morpholinylanilinoquinazoline derivatives for use as antiviral agents |
04/18/2007 | CN1950344A Pharmaceutical compositions |
04/18/2007 | CN1950081A Arylalkylamino-substituted quinazoline analogues |
04/18/2007 | CN1310892C Dithiocarbamate derivatives and their use as antibacterial agents |
04/17/2007 | US7205405 Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one |
04/17/2007 | US7205310 inflammatory conditions such as multiple sclerosis |
04/17/2007 | US7205309 Obesity therapy; administering orlistat |
04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
04/17/2007 | US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
04/17/2007 | US7205260 Uracil derivative and protoporphyrinogen oxidase-inhibiting N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoaxazine-6-yl)cyclohex-1-ene-1,2-dicarboxamide and N-[2,4-dichloro-5-[4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]methansulfonamide; orchards, soybeans |
04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
04/17/2007 | CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
04/17/2007 | CA2141589C Antiretroviral enantiomeric nucleotide analogs |
04/17/2007 | CA2106882C Azaquinoxalines, processes for their preparation and their use |
04/12/2007 | WO2007041666A1 Preparation of rosuvastatin |
04/12/2007 | WO2007041634A1 Pyrimidine amide compounds as pgds inhibitors |
04/12/2007 | WO2007041366A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
04/12/2007 | WO2007041324A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
04/12/2007 | WO2007041270A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
04/12/2007 | WO2007040940A1 Diastereomeric purification of rosuvastatin |
04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
04/12/2007 | WO2007039499A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
04/12/2007 | WO2007039470A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
04/12/2007 | WO2007039112A1 Novel phloroglucinol derivatives having selectin ligand activity |
04/12/2007 | WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases |
04/12/2007 | WO2006104889A3 Novel compounds |
04/12/2007 | WO2006078598A3 Mitotic kinesin inhibitors |
04/12/2007 | WO2006063792A3 Crystal structure of enzyme and uses thereof |
04/12/2007 | WO2006021458A3 Pyrimidine derivatives |
04/12/2007 | WO2006020830A3 Bisaryl-sulfonamides |
04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
04/12/2007 | CA2851103A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
04/12/2007 | CA2625290A1 Preparation of rosuvastatin |
04/12/2007 | CA2624801A1 Diastereomeric purification of rosuvastatin |
04/12/2007 | CA2624524A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
04/12/2007 | CA2624450A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
04/12/2007 | CA2624020A1 Method for preparing (3-chloro-4-fluorophenyl)-(4-fluoro-4-{[(5methyl-pyrimidin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone and novel intermediate pyrimidine derivatives |
04/12/2007 | CA2623686A1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
04/12/2007 | CA2623045A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
04/12/2007 | CA2622467A1 Novel phloroglucinol derivatives having selectin ligand activity |
04/12/2007 | CA2621040A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
04/11/2007 | EP1772151A2 Method and compositions for the synthesis of bch-189 and related compounds |
04/11/2007 | EP1771452A2 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
04/11/2007 | EP1771447A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
04/11/2007 | EP1771427A1 Prostaglandin analogs |
04/11/2007 | EP1771422A1 Quinazolinone derivatives as parp inhibitors |
04/11/2007 | EP1771421A1 N-hydroxyamide derivatives and use thereof |
04/11/2007 | EP1771418A2 Large conductance calcium-activated k channel opener |
04/11/2007 | EP1771176A2 Methods and compositions |
04/11/2007 | EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents |
04/11/2007 | CN1946703A Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
04/11/2007 | CN1946701A Tri-substituted ureas as cytokine inhibitors |
04/11/2007 | CN1946700A Tri-substituted ureas as cytokine inhibitors |
04/11/2007 | CN1309719C Derivative of phenylamide pyrimidine and application thereof |
04/11/2007 | CN1309710C Pyrimidine derivitive |
04/10/2007 | US7202368 Process for the preparation of 4-(benzimidazolymethylamino) benzamidines |
04/10/2007 | US7202360 Reacting 2,4-difluorophenyl (4-piperidinyl) methanone oxime hydrochloride and 3-(2-haloethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one in an aqueous alkali solution: high yeild when alkali hydroxide concentration is in the range of 20 to 40% |
04/10/2007 | US7202253 Cycloalkyl inhibitors of potassium channel function |
04/10/2007 | US7202251 Bicyclic anilide spirohydantoin CGRP receptor antagonists |
04/10/2007 | US7202244 Chk-1 inhibitors |
04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
04/10/2007 | CA2104148C Process for the preparation of substituted benzenes and benzene sulfonic acid and derivatives thereof and a process for the preparation of n,n'-substituted ureas |
04/05/2007 | WO2007036713A2 Chemical process |
04/05/2007 | WO2007036477A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
04/05/2007 | WO2007000392A3 Chloro-substituted guanidines |
04/05/2007 | US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
04/05/2007 | US20070078106 A 5-substituted uracil or 5,6-dihydro-5-substituted uracil, potentiate 5-fluorouracil; 5-substituent is selected from bromo, ido, cyano, halo-substituted C1-4 alkyl, C2-6 alkenyl, 1-halo-C2-6 alkenyl andhalo-substituted C2-6 alkynyl; antitumor agents; anticarcinogenic agents |
04/05/2007 | US20070077196 Radiolabeled thymidine solid-phase extraction purification method |
04/05/2007 | CA2745829A1 Chemical process |
04/05/2007 | CA2623063A1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
04/05/2007 | CA2621967A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
04/04/2007 | EP1768978A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
04/04/2007 | EP1768964A1 Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer |
04/04/2007 | EP1768963A2 Cancer treatment method |
04/04/2007 | EP1768951A2 Non-natural amino acids |
04/04/2007 | EP1219609B1 Aromatic nitrogenous six-membered ring compounds |
04/04/2007 | CN1942188A Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
04/04/2007 | CN1939910A Amino-metadiazine compound and its salt, its preparation and pharmaceutical use |
04/04/2007 | CN1939896A Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
04/03/2007 | US7199392 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds |
04/03/2007 | US7199239 Chemical compounds |
04/03/2007 | US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists |
04/03/2007 | US7199119 Antiinflammation agents |
04/03/2007 | US7198958 Method for increasing hydrophilicity of fluorescent label compounds |
04/03/2007 | CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
04/03/2007 | CA2309350C Purine derivatives and medicaments comprising the same as active ingredient |
04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
04/03/2007 | CA2288140C Farnesyltransferase inhibiting quinazolinones |
03/29/2007 | WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
03/29/2007 | US20070073060 Tricycle indole hydroxyethlamine derivatives and their use in the treatment of alzheimer's disease |
03/29/2007 | US20070072942 Statin derivatives |
03/29/2007 | US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
03/29/2007 | US20070072876 Novel pyrimidine carboxamides |